Center for Scientific Review; Notice of Closed Meetings, 66344-66345 [2020-23046]
Download as PDF
<![CDATA[
66344
Federal Register / Vol. 85, No. 202 / Monday, October 19, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
NCCIH Workshop 2020: Exploring the
Mechanisms Underlying Analgesic
Properties of Minor Cannabinoids and
Terpenes
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIDCD.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual grant
applications conducted by the National
Institute On Deafness And Other
Communication Disorders, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Name of Committee: Board of Scientific
Counselors, NIDCD.
Date: November 2, 2020.
Time: 4:00 p.m. to 4:45 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Thomas Baer Friedman,
Ph.D., Chief, Laboratory of Molecular
Medicine, National Institute on Deafness &
Comm Disorders, National Institute of
Health, 35 Convent Drive, Bethesda, MD
20892, (301) 496–7882, friedman@
nidcd.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/advisorycommittees, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health,
HHS).
Dated: October 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23076 Filed 10–16–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:05 Oct 16, 2020
Jkt 253001
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Dated: October 13, 2020.
Helene Langevin,
Director, National Center for Complementary
and Integrative Health, National Institutes of
Health.
[FR Doc. 2020–22990 Filed 10–16–20; 8:45 am]
BILLING CODE 4140–01–P
Notice.
The National Center for
Complementary and Integrative Health
(NCCIH) will hold a workshop on
October 23, 2020. The topic of this
workshop will be ‘‘Exploring the
Mechanisms Underlying Analgesic
Properties of Minor Cannabinoids and
Terpenes’’. The overall goals of this
workshop are to convene principal
investigators funded by NCCIH on the
topic of the analgesic properties of
minor cannabinoids and terpenes from
natural products and the underlying
mechanisms as well as to discuss
current research barriers and
opportunities on this topic.
DATES: The Meeting will be held on
October 23, 2020, from 9:45 a.m. to 3:00
p.m. (ET).
ADDRESSES: This workshop will be
livestreamed via videocast. Registration
is requested via https://nccih_cbd_
workshop.eventbrite.com.
SUMMARY:
For
information concerning this meeting,
contact Dr. Inna Belfer, Program
Director, Basic and Mechanistic
Research, Division of Extramural
Research, National Center for
Complementary and Integrative Health,
Telephone: 301–435–1573; Email:
inna.belfer@nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with 42 U.S.C. 287c–21, of
the Public Health Service Act, as
amended and in keeping with the
mission of the National Center for
Complementary and Integrative Health
(NCCIH) is to define, through rigorous
scientific investigation, the usefulness
and safety of complementary and
integrative interventions and their roles
in improving health and health care.
This workshop is aligned with NCCIH’s
mission to support research on the
fundamental science, safety, and
usefulness of complementary and
integrative health approaches.
Specifically, minor cannabinoids and
terpenes from natural products are part
of complementary interventions
supported by NCCIH. The workshop is
also aligned with NCCIH’s strategic
goals of advancing understanding of
FOR FURTHER INFORMATION CONTACT:
PO 00000
basic biological mechanisms of action of
natural products and improving care for
hard-to-manage symptoms, such as
pain.
Frm 00045
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
November 04, 2020, 09:00 a.m. to
November 05, 2020, 02:00 p.m.,
National Institutes of Health, Rockledge
II, 6701 Rockledge Drive, Bethesda, MD
20892 which was published in the
Federal Register on October 06, 2020,
85 FR Page 63123.
The meeting is scheduled for 11/04/
2020 starting at 9:00 a.m. and ending on
11/05/2020 at 2:00 p.m. The meeting
location remains the same. The meeting
is closed to the public.
Dated: October 13, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23044 Filed 10–16–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\19OCN1.SGM
19OCN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 202 / Monday, October 19, 2020 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Orthopedic, Musculoskeletal, Oral,
Skin and Rehabilitation Sciences.
Date: November 16–17, 2020.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A. Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 237–
9931, ansaria@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
Population and Public Health Approaches to
HIV/AIDS Study Section.
Date: November 16–17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award (R35—Clinical Trial Optional).
Date: November 16–17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–3717, jessica.smith6@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Diagnostics and Treatments
(CDT).
Date: November 16–17, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Elena CardenasCorona, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 867–5309, maria.cardenascorona@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Disease Prevention and
Management, Risk Reduction and Health
Behavior Change.
Date: November 16–17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
18:05 Oct 16, 2020
Jkt 253001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J. McQuestion,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, (301) 480–
1276, mike.mcquestion@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Applications: Drug Discovery and
Development.
Date: November 16–17, 2020.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, (301) 435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Emergency
Awards: RADx-rad Data Coordination Center
(U24).
Date: November 16, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenchi Liang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, (301) 435–
0681, liangw3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award (R35—Clinical Trial Optional).
Date: November 17–18, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 435–
1722, eissenstatma@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 13, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–23046 Filed 10–16–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
66345
DEPARTMENT OF THE INTERIOR
National Park Service
[NPS–WASO–NRNHL–DTS#–
31011;PPWOCRADI0, PCU00RP14.R50000]
National Register of Historic Places;
Notification of Pending Nominations
and Related Actions
National Park Service, Interior.
Notice.
AGENCY:
ACTION:
The National Park Service is
soliciting electronic comments on the
significance of properties nominated
before October 3, 2020, for listing or
related actions in the National Register
of Historic Places.
DATES: Comments should be submitted
electronically by November 3, 2020.
ADDRESSES: Comments are encouraged
to be submitted electronically to
National_Register_Submissions@
nps.gov with the subject line ‘‘Public
Comment on <property or proposed
district name, (County) State>.’’ If you
have no access to email you may send
them via U.S. Postal Service and all
other carriers to the National Register of
Historic Places, National Park Service,
1849 C Street NW, MS 7228,
Washington, DC 20240.
SUPPLEMENTARY INFORMATION: The
properties listed in this notice are being
considered for listing or related actions
in the National Register of Historic
Places. Nominations for their
consideration were received by the
National Park Service before October 3,
2020. Pursuant to Section 60.13 of 36
CFR part 60, comments are being
accepted concerning the significance of
the nominated properties under the
National Register criteria for evaluation.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Nominations submitted by State or
Tribal Historic Preservation Officers:
SUMMARY:
ALABAMA
Macon County
Macon County High School, 500 East Main
St., Notasulga, SG100005781
ARKANSAS
Benton County
Shaw-Blair House, 11976 Tyson Rd., Lowell,
SG100005757
E:\FR\FM\19OCN1.SGM
19OCN1
]]>Agencies
[Federal Register Volume 85, Number 202 (Monday, October 19, 2020)]
[Notices]
[Pages 66344-66345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23046]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 66345]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Orthopedic, Musculoskeletal, Oral, Skin and
Rehabilitation Sciences.
Date: November 16-17, 2020.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A. Ansari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD
20892, (301) 237-9931, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; Population and Public Health Approaches to HIV/AIDS Study
Section.
Date: November 16-17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, (301) 435-1137, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-367: Maximizing Investigators' Research Award (R35--
Clinical Trial Optional).
Date: November 16-17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-3717,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Cancer Diagnostics and Treatments (CDT).
Date: November 16-17, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Elena Cardenas-Corona, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Disease Prevention and Management, Risk
Reduction and Health Behavior Change.
Date: November 16-17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J. McQuestion, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD
20892, (301) 480-1276, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business Applications: Drug Discovery and Development.
Date: November 16-17, 2020.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, (301) 435-1180, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Emergency Awards: RADx-rad Data Coordination Center (U24).
Date: November 16, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, (301) 435-
0681, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-367: Maximizing Investigators' Research Award (R35--
Clinical Trial Optional).
Date: November 17-18, 2020.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D., Scientific Review
Officer, BCMB IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD
20892, (301) 435-1722, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 13, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-23046 Filed 10-16-20; 8:45 am]
BILLING CODE 4140-01-P
